DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of DX-8951f in treating patients who have
metastatic cancer of the pancreas that has not been previously treated or that has not
responded to previous chemotherapy.